Development, problems and countermeasures of laparoscopic radical gastrectomy for gastric cancer in China in the past 20 years

doi:10.3877/cma.j.issn.1674-3946.2021.02.002

Abstract

Abstract:

Although laparoscopic radical surgery for gastric cancer was developed relatively late in China, it has developed rapidly in the past 20 years by taking advantage of large number of clinical cases. For the application of laparoscopy in advanced gastric cancer radical surgery, Chinese scholars have obtained great achievements in high-level evidence-based medical research on surgical efficacy, surgical approach exploration, and indoxyanine green (ICG) tracing assisted lymph node dissection . However, with the rapid development of technology, there still exist problems that overemphasize the accumulation of clinical cases and ignore the normative development of technology and the accumulation and analysis of clinical data. It is believed that with the gradual establishment and improvement of standardized training system, qualification access system and surgical quality control mechanism, multi-disciplinary multi-center collaboration and big data analysis, laparoscopic gastric cancer surgery will be more comprehensive and more standardized in the surgical treatment of gastric cancer.

Key words: Stomach neoplasms, Laparoscopes, Gastrectomy, China, Clinical study, Advance

Changming Huang, Qiyue Chen, Zhiyu Liu, Qing Zhong. Development, problems and countermeasures of laparoscopic radical gastrectomy for gastric cancer in China in the past 20 years[J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2021, 15(02): 123-128.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhpwkssxzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1674-3946.2021.02.002

https://zhpwkssxzz.cma-cmc.com.cn/EN/Y2021/V15/I02/123

Figures/Tables 6

References 44

[1]	Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: Cancer J Clin, 2018, 68(6): 394-424.
[2]	Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
[3]	Kitano S, Iso Y, Moriyama M, et al. Laparoscopy-assisted Billroth I gastrectomy[J]. Surg Laparosc Endosc, 1994, 4(2): 146-148.
[4]	Torre LA, Siegel RL, Ward EM, et al. Global Cancer Incidence and Mortality Rates and Trends--An Update[J]. Cancer Epidemiol Biomarkers Prev, 2016, 25(1): 16-27.
[5]	Zhao JK, Wu M, Kim CH, et al. Jiangsu Four Cancers Study: a large case-control study of lung, liver, stomach, and esophageal cancers in Jiangsu Province, China[J]. Eur J Cancer Prev, 2017, 26(4): 357-364.
[6]	Kim HH, Hyung WJ, Cho GS, et al. Morbidity and mortality of laparoscopic gastrectomy versus open gastrectomy for gastric cancer: an interim report--a phase III multicenter, prospective, randomized Trial (KLASS Trial) [J]. Anna Surg, 2010, 251(3): 417-420.
[7]	Cho SY, Lee KS, Kim JH, et al. Effect of combined systematized behavioral modification education program with desmopressin in patients with nocturia: a prospective, multicenter, randomized, and parallel study[J]. Int Neurourol J, 2014, 18(4): 213-220.
[8]	Honda M, Hiki N, Kinoshita T, et al. Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study[J]. Ann Surg, 2016, 264(2): 214-222.
[9]	Kim W, Kim HH, Han SU, et al. Decreased Morbidity of Laparoscopic Distal Gastrectomy Compared With Open Distal Gastrectomy for Stage I Gastric Cancer: Short-term Outcomes From a Multicenter Randomized Controlled Trial (KLASS-01) [J]. Ann Surg, 2016, 263(1): 28-35.
[10]	Katai H, Mizusawa J, Katayama H, et al. Short-term surgical outcomes from a phase III study of laparoscopy-assisted versus open distal gastrectomy with nodal dissection for clinical stage IA/IB gastric cancer: Japan Clinical Oncology Group Study JCOG0912[J]. Gastric Cancer, 2017, 20(4): 699-708.
[11]	Huang CM, Zheng CH. Laparoscopic Gastrectomy for Gastric Cancer[J]. Springer, 2015.
[12]	Huang CM, Zheng CH, Li P, et al. Atlas of Laparoscopic Gastrectomy for Gastric Cancer[J]. Springer, 2019.
[13]	Chen QY, Huang CM, Lin JX, et al. Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach[J]. Ann Surg Oncol, 2016, 23(3): 951.
[14]	Huang CM, Chen QY, Lin JX, et al. Laparoscopic Suprapancreatic Lymph Node Dissection for Advanced Gastric Cancer Using a Left-Sided Approach[J]. Ann Surg Oncol, 2015, 22(7): 2351.
[15]	Chen RF, Huang CM, Chen QY, et al. Why the Proximal Splenic Artery Approach is the Ideal Approach for Laparoscopic Suprapancreatic Lymph Node Dissection in Advanced Gastric Cancer? A Large-Scale Vascular-Anatomical-Based Study[J]. Medicine (Baltimore), 2015, 94(18): e832.
[16]	Liang H. Standardize the lymphadenectomy from the rules of lymph nodes metastasis for advanced gastric cancer (in Chinese) [J]. Chin J Gastrointest Surg, 2011, 14(2): 86-89.
[17]	Huang CM, Chen QY, Lin JX, et al. Laparoscopic spleen-preserving no. 10 lymph node dissection for advanced proximal gastric cancer using a left approach[J]. Ann Surg Oncol, 2014, 21(6): 2051.
[18]	Jia-Bin W, Chang-Ming H, Chao-Hui Z, et al. Laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer in left approach: a new operation procedure[J]. World J Surg Oncol, 2012, 10: 241.
[19]	Huang CM, Chen QY, Lin JX, et al. Huang's three-step maneuver for laparoscopic spleen-preserving No. 10 lymph node dissection for advanced proximal gastric cancer[J]. Chin J Cancer Res, 2014, 26(2): 208-210.
[20]	Yu J, Hu J, Huang C, et al. The impact of age and comorbidity on postoperative complications in patients with advanced gastric cancer after laparoscopic D2 gastrectomy: results from the Chinese laparoscropic gastrointestinal surgery study (CLASS) group[J]. Eur J Surg Oncol, 2013, 39(10): 1144-1149.
[21]	Hu YF, Huang CM, Sun YH, et al. Morbidity and Mortality of Laparoscopic Versus Open D2 Distal Gastrectomy for Advanced Gastric Cancer: A Randomized Controlled Trial[J]. J Clin, 2016, 34(12): 1350-1357.
[22]	Yu J, Huang C, Sun Y, et al. Effect of Laparoscopic vs Open Distal Gastrectomy on 3-Year Disease-Free Survival in Patients With Locally Advanced Gastric Cancer: The CLASS-01 Randomized Clinical Trial[J]. JAMA, 2019, 321(20): 1983-1992.
[23]	Monig SP, Collet PH, Baldus SE, et al. Splenectomy in proximal gastric cancer: frequency of lymph node metastasis to the splenic hilus[J]. J Surg Oncol, 2001, 76(2): 89-92.
[24]	Sasada S, Ninomiya M, Nishizaki M, et al. Frequency of lymph node metastasis to the splenic hilus and effect of splenectomy in proximal gastric cancer[J]. Anticancer Res, 2009, 29(8): 3347-3351.
[25]	Zhu GL, Sun Z, Wang ZN, et al. Splenic hilar lymph node metastasis independently predicts poor survival for patients with gastric cancers in the upper and/or the middle third of the stomach[J]. J Surg Oncol, 2012, 105(8): 786-792.
[26]	Methasate A, Trakarnsanga A, Akaraviputh T, et al. Lymph node metastasis in gastric cancer: result of D2 dissection[J]. J Med Assoc Thai, 2010, 93(3): 310-317.
[27]	Huang CM, Zhang JR, Zheng CH, et al. A 346 case analysis for laparoscopic spleen-preserving no.10 lymph node dissection for proximal gastric cancer: a single center study[J]. PLoS One, 2014, 9(9): e108480.
[28]	Zhang CH, Wu AW, Li ZY, et al. [Analysis of splenic hilar lymph node metastasis in advanced gastric cancer and dissection techniques] [J]. Zhonghua Wei Chang Wai Ke Za Zhi, 2011, 14(8): 589-592.
[29]	Shin SH, Jung H, Choi SH, et al. Clinical significance of splenic hilar lymph node metastasis in proximal gastric cancer[J]. Ann Surg Oncol, 2009, 16(5): 1304-1309.
[30]	Guo X, Peng Z, Lv XH, et al. Randomized controlled trial comparing short-term outcomes of laparoscopic and open spleen-preserving splenic hilar lymphadenectomy for advanced proximal gastric cancer: An interim report[J]. J Surg Oncol, 2018, 118(8): 1264-1270.
[31]	Zhang CH, Zhan WH, He YL, et al. Spleen preservation in radical surgery for gastric cardia cancer[J]. Ann Surg Oncol, 2007, 14(4): 1312-1319.
[32]	Ma ZM, Shi G, Chen X, et al. Laparoscopic splenic hilar lymph node dissection for advanced gastric cancer: to be or not to be[J]. Ann Transl Med, 2019, 7(14): 343.
[33]	Zheng CH, Xu YC, Zhao G, et al. Safety and feasibility of laparoscopic spleen-preserving No. 10 lymph node dissection for locally advanced upper third gastric cancer: a prospective, multicenter clinical trial[J]. Surg Endosc, 2020, 34(11): 5062-5073.
[34]	Smith DD, Schwarz RR, Schwarz RE. Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database[J]. J Clin Oncol, 2005, 23(28): 7114-7124.
[35]	Son T, Hyung WJ, Lee JH, et al. Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer[J]. Cancer, 2012, 118(19): 4687-4693.
[36]	Seevaratnam R, Bocicariu A, Cardoso R, et al. A meta-analysis of D1 versus D2 lymph node dissection[J]. Gastric Cancer, 2012, 15 Suppl 1: S60-S69.
[37]	Songun I, Putter H, Kranenbarg EMK, et al. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial[J]. Lancet Oncol, 2010, 11(5): 439-449.
[38]	Vahrmeijer AL, Hutteman M, van der Vorst JR, et al. Image-guided cancer surgery using near-infrared fluorescence[J]. Nat Rev Clin Oncol, 2013, 10(9): 507-518.
[39]	Valente SA, Al-Hilli Z, Radford DM, et al. Near Infrared Fluorescent Lymph Node Mapping with Indocyanine Green in Breast Cancer Patients: A Prospective Trial[J]. J Am Coll Surg, 2019, 228(4): 672-678.
[40]	Yamashita S, Tokuishi K, Anami K, et al. Video-assisted thoracoscopic indocyanine green fluorescence imaging system shows sentinel lymph nodes in non-small-cell lung cancer[J]. J Thorac Cardiovasc Surg, 2011, 141(1): 141-144.
[41]	Tajima Y, Murakami M, Yamazaki K, et al. Sentinel node mapping guided by indocyanine green fluorescence imaging during laparoscopic surgery in gastric cancer[J]. Ann Surg Oncol, 2010, 17(7): 1787-1793.
[42]	Yano K, Nimura H, Mitsumori N, et al. The efficiency of micrometastasis by sentinel node navigation surgery using indocyanine green and infrared ray laparoscopy system for gastric cancer[J]. Gastric Cancer, 2012, 15(3): 287-291.
[43]	Huh YJ, Lee HJ, Kim TH, et al. Efficacy of Assessing Intraoperative Bowel Perfusion with Near-Infrared Camera in Laparoscopic Gastric Cancer Surgery[J]. J Laparoendosc Adv Surg Tech A, 2019, 29(4): 476-483.
[44]	Chen QY, Xie JW, Zhong Q, et al. Safety and Efficacy of Indocyanine Green Tracer-Guided Lymph Node Dissection During Laparoscopic Radical Gastrectomy in Patients With Gastric Cancer: A Randomized Clinical Trial[J]. JAMA Surg, 2020, 155(4): 300-311.

Please choose a citation manager

Content to export